FuturHealth is designed to remove barriers like insurance restrictions and geographic limitations
Your eligibility for Semaglutide depends on several factors, including Type 2 diabetes or obesity, overall health status, and specific criteria outlined by your healthcare professionals
Comprehensive evaluation of rhythm monitoring strategies in screening for atrial fibrillation: insights from patients at risk monitored long term with an implantable loop recorder
Regular B12 injections help your body naturally break down fat cells and protein to convert them into energy
Schedule a consultation today and take the next step toward feeling stronger, sharper, and more balanced
Notably, about one in four of these patients did not carry a type 2 diabetes diagnosis , suggesting that a substantial portion of GLP-1 use is being driven by weight loss and other emerging indications outside of diabetes care (Figure 2)